RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Piletz to Blood Platelets

This is a "connection" page, showing publications John Piletz has written about Blood Platelets.
Connection Strength

2.920
  1. Piletz J, Baker R, Halaris A. Platelet imidazoline receptors as state marker of depressive symptomatology. J Psychiatr Res. 2008 Jan; 42(1):41-9.
    View in: PubMed
    Score: 0.273
  2. Zhu H, Halaris A, Piletz JE. Atypical [(3)H]clonidine binding sites in human caudate and platelets on cryostat-cut sections. Ann N Y Acad Sci. 2003 Dec; 1009:296-301.
    View in: PubMed
    Score: 0.222
  3. Zhu H, Piletz JE. Association between I(2) binding sites and monoamine oxidase-B activity in platelets. Ann N Y Acad Sci. 2003 Dec; 1009:347-52.
    View in: PubMed
    Score: 0.222
  4. Zhu H, Hayes J, Chen M, Baldwin J, Piletz JE. Relationship between platelet imidazoline receptor-binding peptides and candidate imidazoline-1 receptor, IRAS. Ann N Y Acad Sci. 2003 Dec; 1009:439-46.
    View in: PubMed
    Score: 0.222
  5. Halaris A, Zhu H, Ali J, Nasrallah A, Lindsay De Vane C, Piletz JE. Down-regulation of platelet imidazoline-1-binding sites after bupropion treatment. Int J Neuropsychopharmacol. 2002 Mar; 5(1):37-46.
    View in: PubMed
    Score: 0.196
  6. Halaris A, Zhu H, Feng Y, Piletz JE. Plasma agmatine and platelet imidazoline receptors in depression. Ann N Y Acad Sci. 1999 Jun 21; 881:445-51.
    View in: PubMed
    Score: 0.163
  7. Ivanov TR, Feng Y, Wang H, Regunathan S, Reis DJ, Chikkala DN, Gupta P, Jones JC, Piletz JE. Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists. J Psychiatr Res. 1998 Mar-Apr; 32(2):65-79.
    View in: PubMed
    Score: 0.149
  8. Piletz JE, Zhu H, Chikkala DN. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. J Pharmacol Exp Ther. 1996 Nov; 279(2):694-702.
    View in: PubMed
    Score: 0.136
  9. Piletz JE, Halaris A, Nelson J, Qu Y, Bari M. Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder. J Psychiatr Res. 1996 May-Jun; 30(3):147-68.
    View in: PubMed
    Score: 0.131
  10. Piletz JE, Halaris AE, Chikkala D, Qu Y. Platelet I1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients. J Psychiatr Res. 1996 May-Jun; 30(3):169-84.
    View in: PubMed
    Score: 0.131
  11. Piletz JE, Sletten K. Nonadrenergic imidazoline binding sites on human platelets. J Pharmacol Exp Ther. 1993 Dec; 267(3):1493-502.
    View in: PubMed
    Score: 0.111
  12. Piletz JE, Halaris A, Saran A, Marler MR. Desipramine lowers tritiated para-aminoclonidine binding in platelets of depressed patients. Arch Gen Psychiatry. 1991 Sep; 48(9):813-20.
    View in: PubMed
    Score: 0.095
  13. Piletz JE, Sarasua M, Whitehouse P, Chotani M. Intracellular membranes are more fluid in platelets of Alzheimer's disease patients. Neurobiol Aging. 1991 Sep-Oct; 12(5):401-6.
    View in: PubMed
    Score: 0.095
  14. Piletz JE, Andorn AC, Unnerstall JR, Halaris A. Binding of [3H]-p-aminoclonidine to alpha 2-adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes. Biochem Pharmacol. 1991 Jul 15; 42(3):569-84.
    View in: PubMed
    Score: 0.094
  15. Piletz JE, Sarasua M, Chotani M, Saran A, Halaris A. Relationship between membrane fluidity and adrenoceptor binding in depression. Psychiatry Res. 1991 Jul; 38(1):1-12.
    View in: PubMed
    Score: 0.094
  16. Piletz JE, Halaris A, Saran A, Marler M. Elevated 3H-para-aminoclonidine binding to platelet purified plasma membranes from depressed patients. Neuropsychopharmacology. 1990 Jun; 3(3):201-10.
    View in: PubMed
    Score: 0.087
  17. Piletz JE, Halaris A. Comparison of 3H-para-aminoclonidine binding to different platelet preparations. J Neural Transm Gen Sect. 1990; 82(1):11-29.
    View in: PubMed
    Score: 0.084
  18. Piletz JE, Halaris A. Super high affinity 3H-para-aminoclonidine binding to platelet adrenoceptors in depression. Prog Neuropsychopharmacol Biol Psychiatry. 1988; 12(4):541-53.
    View in: PubMed
    Score: 0.074
  19. Piletz JE, Schubert DS, Halaris A. Evaluation of studies on platelet alpha 2 adrenoreceptors in depressive illness. Life Sci. 1986 Nov 03; 39(18):1589-616.
    View in: PubMed
    Score: 0.068
  20. Piletz JE, Andorn AC, Halaris A. 3H-clonidine and 3H-yohimbine binding to glass fiber filters: implications for studies with platelet membranes. Psychopharmacology (Berl). 1986; 89(3):370-7.
    View in: PubMed
    Score: 0.064
  21. Halaris A, Piletz JE. Relevance of imidazoline receptors and agmatine to psychiatry: a decade of progress. Ann N Y Acad Sci. 2003 Dec; 1009:1-20.
    View in: PubMed
    Score: 0.055
  22. Piletz JE, Halbreich U. Imidazoline and alpha(2a)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy. Biol Psychiatry. 2000 Nov 01; 48(9):932-9.
    View in: PubMed
    Score: 0.045
  23. Piletz JE, Andrew M, Zhu H, Feng YZ, Rains J, Halaris A. Alpha 2-adrenoceptors and I1-imidazoline binding sites: relationship with catecholamines in women of reproductive age. J Psychiatr Res. 1998 Mar-Apr; 32(2):55-64.
    View in: PubMed
    Score: 0.037
  24. Piletz JE, Halaris A. Involvement of I1-imidazoline receptors in mood disorders. Ann N Y Acad Sci. 1995 Jul 12; 763:510-9.
    View in: PubMed
    Score: 0.031
  25. Halbreich U, Piletz JE, Carson S, Halaris A, Rojansky N. Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol Psychiatry. 1993 Nov 15; 34(10):676-86.
    View in: PubMed
    Score: 0.028
  26. Piletz JE, Halaris A. Yohimbine and clonidine recognize different states of adrenergic receptors on human platelets: reconsideration of studies on platelet alpha-2 receptors in depressive illness. Psychopharmacol Bull. 1985; 21(3):573-8.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support